SlideShare a Scribd company logo
Randomized Controlled Trials
Part 2
Outcomes
•
•
•
•

Identify the RCT study design
Discuss the various characteristics of RCTs
Describe measures of effectiveness in RCTs
Identify tools of critical appraisal of RCTs
Study Types

MAIN TYPES OF STUDY DESIGN
Crosssectional
Retrospective
Cohort

Observational
Longitudinal

Study Design

Prospective
Cohort

Experimental
Case-control
RCT Study Design

Population

sample

Randomization
& Allocation
Concealment

Intervention

Disease

Placebo

NO
Disease

NO
Disease

Disease
Characteristics of RCTs
•
•
•
•
•
•
•
•
•

Prospective:
Eligibility criteria for participants
Settings and locations
Description of the interventions
Defined pre-specified outcomes
How sample size was determined
Allocation Concealment
Blinding
Statistical methods
Characteristics of RCTs

Statistical methods used to compare groups
• Intention-to-treat analysis
Experimental
(composite)

Control
(Amalgam)

100

100
20
??

80

8F

12

8/80 = 10%

100

72 S

8

20/100= 20%

20 F

80 S

20/100= 20%
Characteristics of RCTs

Statistical methods used to compare groups
• Intention-to-treat analysis
Experimental
(composite)

Control
(Amalgam)

100

100
20
??

80

8F

20

28/100= 28%

100

72 S

20 F

80 S

20/100= 20%
Characteristics of RCTs

Statistical methods used to compare groups
• Intention-to-treat analysis
• Analysis by which all participants are included
in the arm to which they were allocated,
whether or not they received (or completed)
the intervention given to that arm.
• Intention-to-treat analysis prevents bias caused
by the loss of participants
Characteristics of RCTs

Statistical methods used to compare groups
• Number Needed to treat
– Risk Difference (Absolute Risk Reduction)

• Relative Risk
• Odds Ratio
Characteristics of RCTs

Statistical methods used to compare groups
• Number Needed to treat
107 patients (30-40 years old) with mild periodontitis

GingiFree
Placebo

No Inflammation
51
38

Inflammation
4
14

What proportion had inflammation in GingiFree group?
4 out of 55 or 7.3%
This is called: Experimental Event Rate (EER) or Risk
Characteristics of RCTs

Statistical methods used to compare groups
• Number Needed to treat
107 patients (30-40 years old) with mild periodontitis

GingiFree
Placebo

No Inflammation
51
38

Inflammation
4
14

What proportion had inflammation in placebo group?
14 out of 52 or 26.9%
This is called: Control Event Rate (CER) or Risk
Characteristics of RCTs

Statistical methods used to compare groups
• Number Needed to treat
107 patients (30-40 years old) with mild periodontitis

GingiFree
Placebo

No Inflammation
51
38

Inflammation
4
14

What is the difference in risk of inflammation between
the two groups?
CER – EER = ARR (Absolute Risk Reduction)
26.9% - 7.3% = 19.6
Characteristics of RCTs

Statistical methods used to compare groups
• Number Needed to treat
107 patients (30-40 years old) with mild periodontitis

GingiFree
Placebo

No Inflammation
51
38

Inflammation
4
14

How many people do you need to treat with GingiFree
to prevent 1 additional inflammation?
Number Needed to Treat (NNT)
1 / ARR
Characteristics of RCTs

Statistical methods used to compare groups
• Number Needed to treat
107 patients (30-40 years old) with mild periodontitis

GingiFree
Placebo

No Inflammation
51
38

Inflammation
4
14

How many people do you need to treat with GingiFree
to prevent 1 additional inflammation?
Number Needed to Treat (NNT) = 1/ARR
1 / 19.6 = 5.1
Characteristics of RCTs

Statistical methods used to compare groups
107 patients (30-40 years old) with mild periodontitis

GingiFree
Placebo

No Inflammation
51
38

Inflammation
4
14

What is the risk of developing inflammation in the
experimental group relative to the control group?
EER/CER = Relative Risk (Risk Ratio)
7.3/ 26.9 = 0.27
Characteristics of RCTs

Statistical methods used to compare groups
107 patients (30-40 years old) with mild periodontitis

GingiFree
Placebo

No Inflammation
51
38

Inflammation
4
14

What is the Odds Ratio of the study?
Odds = 4/51 = 0.078 and 14/38 = 0.368
Odds Ratio = Odds of exp/Odds of control
= 0.078/0.368 = 0.21
Critical Appraisal of the Evidence
• What are the results?
– How large was the treatment effect?
• Relative risk, mean difference, etc.

– How precise was the estimate of the treatment effect?
• Confidence intervals
Critical Appraisal of the Evidence
• Can I apply the results locally?
– Can the results be applied to my patients?
– Were all clinically important outcomes considered?
– Are the likely treatment benefits worth the potential
harms and costs?
randomized clinical trials II
randomized clinical trials II
The Basics of Critical Appraisal
Critical Appraisal of RCTs
Randomization
The process of randomly allocating participants into
one of the arms of a controlled trial.
- tossing a coin
- computer generated tables
It assures:
all factors are equal
less bias in patient selection
The Basics of Critical Appraisal
Critical Appraisal of RCTs
Randomization
Allocation concealment

The process of preventing foreknowledge of
group assignment in a randomized controlled
trial. The most common method of
concealment is the use of opaque, sealed
envelopes.
The Basics of Critical Appraisal
Critical Appraisal of RCTs
Randomization
Allocation concealment
Blinding
The process of preventing those involved in a trial
from knowing to which comparison group a
particular participant belongs.
The Basics of Critical Appraisal
Critical Appraisal of RCTs
Randomization
Allocation concealment
Blinding
Intention to treat analysis
Analysis by which all participants are included in the
arm to which they were allocated, whether or not
they received (or completed) the intervention given
to that arm. Intention-to-treat analysis prevents bias
caused by the loss of participants
The Basics of Critical Appraisal
Critical Appraisal of RCTs
107 patients (30-40 years old) with mild periodontitis

GingiFree
Placebo

No Inflammation
51
38

Inflammation
4
14

What is the odds of inflammation in the GingiFree group
relative to placebo?
Odds 4/51= 0.07
14/38=0.37
Odds Ratio = 0.07/ 0.37= 0.23

More Related Content

PPTX
Randomized controlled trial: Going for the Gold
PPTX
A.6 confidence intervals
PPTX
Bias in health research
PPTX
Metaanalysis copy
PDF
Power Analysis and Sample Size Determination
PPT
Overview on randomized control trial
PPTX
Confounder and effect modification
PPTX
Stat 3203 -pps sampling
Randomized controlled trial: Going for the Gold
A.6 confidence intervals
Bias in health research
Metaanalysis copy
Power Analysis and Sample Size Determination
Overview on randomized control trial
Confounder and effect modification
Stat 3203 -pps sampling

What's hot (20)

PPTX
Sample size determination
PPTX
Experimental Study
PPTX
Blinding in clinical trilas
PDF
Presenting the results of meta-analysis
PPTX
Survival analysis
PDF
Types of correlation coefficients
PDF
Normality tests
PPTX
Survival analysis
PDF
Critical Appraisal of systematic review and meta analysis articles
PPTX
Observational study
PPT
Doe10 factorial2k blocking
PPTX
systematic review and metaanalysis
PPTX
Randomized clinical trials
PDF
3. Cross sectional
PPTX
8. randomized control trials
PPTX
Experimental study design.pptx
PPTX
PPTX
Biases in RCT.pptx
PPT
Confidence Intervals
PPTX
Types of rct concepts and application
Sample size determination
Experimental Study
Blinding in clinical trilas
Presenting the results of meta-analysis
Survival analysis
Types of correlation coefficients
Normality tests
Survival analysis
Critical Appraisal of systematic review and meta analysis articles
Observational study
Doe10 factorial2k blocking
systematic review and metaanalysis
Randomized clinical trials
3. Cross sectional
8. randomized control trials
Experimental study design.pptx
Biases in RCT.pptx
Confidence Intervals
Types of rct concepts and application
Ad

Viewers also liked (20)

PDF
randomized clinical trials I
PPT
Randomised controlled trials : the basics
PPTX
randomised control trial
PPT
Randomised controlled trials
PPTX
Critical appraisal of randomized clinical trials
PPTX
Randomized Controlled Trial
PPT
Randomised Controlled Trials
PPT
Statistical analysis of clinical data isi 30 01 07
PDF
6. Randomised controlled trial
PPTX
Study design in research
PPTX
Randomized Controlled Trial
PPT
PPT
Integrated aspects of rct niper feb 2009 final
PPT
Dhiwahar ppt
PPT
Critically appraise evidence based findings
PPTX
Critical appraisal
PDF
Evidence based practice_step_by_step__critical.26
PPTX
Research Methodology 2
PPT
Research Methods 2 Critical Appraisal Of Literature
PPTX
The stepped wedge cluster randomised trial workshop: Session 2
randomized clinical trials I
Randomised controlled trials : the basics
randomised control trial
Randomised controlled trials
Critical appraisal of randomized clinical trials
Randomized Controlled Trial
Randomised Controlled Trials
Statistical analysis of clinical data isi 30 01 07
6. Randomised controlled trial
Study design in research
Randomized Controlled Trial
Integrated aspects of rct niper feb 2009 final
Dhiwahar ppt
Critically appraise evidence based findings
Critical appraisal
Evidence based practice_step_by_step__critical.26
Research Methodology 2
Research Methods 2 Critical Appraisal Of Literature
The stepped wedge cluster randomised trial workshop: Session 2
Ad

Similar to randomized clinical trials II (20)

PPTX
Rc ts b.ph
PPT
Epidemiology Lectures for UG
PPTX
Randomized controlled trial (RCT)- research methodology.pptx
PPTX
Randomized control trial
PPTX
Randomized trial seminar
PPTX
2024_guidline rule_r201-study design.pptx
PPTX
r201-study design for research study.pptx
PPTX
RCTIntrod.pptx
PPTX
Non randomized controlled trial
DOCX
Evidence based surgery
PPTX
RANDOMIZED CONTROL TRIALS PowerPoint presentation
PPT
Randomized CLinical Trail
PPTX
CLINICAL TRIALS public health dentistry.pptx
PPTX
EXPERIMENTAL STUDY DESIGNS from BCBR.pptx
PPTX
Randomised Controlled Trials.pptx
PPTX
RCT_NONRCT_SUBHAJIT.pptx
PPTX
Clinical Trial Design_observational Studies.pptx
PPTX
PPTX
Quick introduction to critical appraisal of quantitative research
PPT
Why to know statistics
Rc ts b.ph
Epidemiology Lectures for UG
Randomized controlled trial (RCT)- research methodology.pptx
Randomized control trial
Randomized trial seminar
2024_guidline rule_r201-study design.pptx
r201-study design for research study.pptx
RCTIntrod.pptx
Non randomized controlled trial
Evidence based surgery
RANDOMIZED CONTROL TRIALS PowerPoint presentation
Randomized CLinical Trail
CLINICAL TRIALS public health dentistry.pptx
EXPERIMENTAL STUDY DESIGNS from BCBR.pptx
Randomised Controlled Trials.pptx
RCT_NONRCT_SUBHAJIT.pptx
Clinical Trial Design_observational Studies.pptx
Quick introduction to critical appraisal of quantitative research
Why to know statistics

More from IAU Dent (20)

PPT
Odontogenic Infection
PPT
Odontogenic Tumors
PPT
Maxillofacial injuries
PPT
Impacted teeth
PPT
Odontogenic Cysts
PDF
Chronic gingivitis
PDF
Plaque control
PPT
8. hypotension & hypertension
PDF
8. Prescription Writing
PDF
7. Adrenocorticosteriods
PPTX
7.a. histamine & antihistaminics
PPTX
8 anticancer drugs
PPT
7 antibiotic-dental
PPT
7.b. sedative hypnotics
PPT
6. peptic ulcer drugs 323
PPT
6. anti drenergic
PPTX
6 beta lactum drugs dental
PPT
4.anti colinergic
PPTX
5 aminoglycosides,macrolides, anti tb dental
PPT
5. opioid analgesics
Odontogenic Infection
Odontogenic Tumors
Maxillofacial injuries
Impacted teeth
Odontogenic Cysts
Chronic gingivitis
Plaque control
8. hypotension & hypertension
8. Prescription Writing
7. Adrenocorticosteriods
7.a. histamine & antihistaminics
8 anticancer drugs
7 antibiotic-dental
7.b. sedative hypnotics
6. peptic ulcer drugs 323
6. anti drenergic
6 beta lactum drugs dental
4.anti colinergic
5 aminoglycosides,macrolides, anti tb dental
5. opioid analgesics

Recently uploaded (20)

PPTX
History and examination of abdomen, & pelvis .pptx
PPTX
neonatal infection(7392992y282939y5.pptx
PPT
Copy-Histopathology Practical by CMDA ESUTH CHAPTER(0) - Copy.ppt
PPTX
Electromyography (EMG) in Physiotherapy: Principles, Procedure & Clinical App...
PDF
CT Anatomy for Radiotherapy.pdf eryuioooop
PPTX
DENTAL CARIES FOR DENTISTRY STUDENT.pptx
PPTX
Uterus anatomy embryology, and clinical aspects
PPTX
Gastroschisis- Clinical Overview 18112311
PPTX
Note on Abortion.pptx for the student note
PPT
Management of Acute Kidney Injury at LAUTECH
PPT
MENTAL HEALTH - NOTES.ppt for nursing students
PPTX
Important Obstetric Emergency that must be recognised
PPTX
Respiratory drugs, drugs acting on the respi system
PPTX
post stroke aphasia rehabilitation physician
PPTX
ca esophagus molecula biology detailaed molecular biology of tumors of esophagus
PPTX
surgery guide for USMLE step 2-part 1.pptx
PDF
Handout_ NURS 220 Topic 10-Abnormal Pregnancy.pdf
PPTX
Fundamentals of human energy transfer .pptx
PDF
Medical Evidence in the Criminal Justice Delivery System in.pdf
PPT
OPIOID ANALGESICS AND THEIR IMPLICATIONS
History and examination of abdomen, & pelvis .pptx
neonatal infection(7392992y282939y5.pptx
Copy-Histopathology Practical by CMDA ESUTH CHAPTER(0) - Copy.ppt
Electromyography (EMG) in Physiotherapy: Principles, Procedure & Clinical App...
CT Anatomy for Radiotherapy.pdf eryuioooop
DENTAL CARIES FOR DENTISTRY STUDENT.pptx
Uterus anatomy embryology, and clinical aspects
Gastroschisis- Clinical Overview 18112311
Note on Abortion.pptx for the student note
Management of Acute Kidney Injury at LAUTECH
MENTAL HEALTH - NOTES.ppt for nursing students
Important Obstetric Emergency that must be recognised
Respiratory drugs, drugs acting on the respi system
post stroke aphasia rehabilitation physician
ca esophagus molecula biology detailaed molecular biology of tumors of esophagus
surgery guide for USMLE step 2-part 1.pptx
Handout_ NURS 220 Topic 10-Abnormal Pregnancy.pdf
Fundamentals of human energy transfer .pptx
Medical Evidence in the Criminal Justice Delivery System in.pdf
OPIOID ANALGESICS AND THEIR IMPLICATIONS

randomized clinical trials II

  • 2. Outcomes • • • • Identify the RCT study design Discuss the various characteristics of RCTs Describe measures of effectiveness in RCTs Identify tools of critical appraisal of RCTs
  • 3. Study Types MAIN TYPES OF STUDY DESIGN Crosssectional Retrospective Cohort Observational Longitudinal Study Design Prospective Cohort Experimental Case-control
  • 4. RCT Study Design Population sample Randomization & Allocation Concealment Intervention Disease Placebo NO Disease NO Disease Disease
  • 5. Characteristics of RCTs • • • • • • • • • Prospective: Eligibility criteria for participants Settings and locations Description of the interventions Defined pre-specified outcomes How sample size was determined Allocation Concealment Blinding Statistical methods
  • 6. Characteristics of RCTs Statistical methods used to compare groups • Intention-to-treat analysis Experimental (composite) Control (Amalgam) 100 100 20 ?? 80 8F 12 8/80 = 10% 100 72 S 8 20/100= 20% 20 F 80 S 20/100= 20%
  • 7. Characteristics of RCTs Statistical methods used to compare groups • Intention-to-treat analysis Experimental (composite) Control (Amalgam) 100 100 20 ?? 80 8F 20 28/100= 28% 100 72 S 20 F 80 S 20/100= 20%
  • 8. Characteristics of RCTs Statistical methods used to compare groups • Intention-to-treat analysis • Analysis by which all participants are included in the arm to which they were allocated, whether or not they received (or completed) the intervention given to that arm. • Intention-to-treat analysis prevents bias caused by the loss of participants
  • 9. Characteristics of RCTs Statistical methods used to compare groups • Number Needed to treat – Risk Difference (Absolute Risk Reduction) • Relative Risk • Odds Ratio
  • 10. Characteristics of RCTs Statistical methods used to compare groups • Number Needed to treat 107 patients (30-40 years old) with mild periodontitis GingiFree Placebo No Inflammation 51 38 Inflammation 4 14 What proportion had inflammation in GingiFree group? 4 out of 55 or 7.3% This is called: Experimental Event Rate (EER) or Risk
  • 11. Characteristics of RCTs Statistical methods used to compare groups • Number Needed to treat 107 patients (30-40 years old) with mild periodontitis GingiFree Placebo No Inflammation 51 38 Inflammation 4 14 What proportion had inflammation in placebo group? 14 out of 52 or 26.9% This is called: Control Event Rate (CER) or Risk
  • 12. Characteristics of RCTs Statistical methods used to compare groups • Number Needed to treat 107 patients (30-40 years old) with mild periodontitis GingiFree Placebo No Inflammation 51 38 Inflammation 4 14 What is the difference in risk of inflammation between the two groups? CER – EER = ARR (Absolute Risk Reduction) 26.9% - 7.3% = 19.6
  • 13. Characteristics of RCTs Statistical methods used to compare groups • Number Needed to treat 107 patients (30-40 years old) with mild periodontitis GingiFree Placebo No Inflammation 51 38 Inflammation 4 14 How many people do you need to treat with GingiFree to prevent 1 additional inflammation? Number Needed to Treat (NNT) 1 / ARR
  • 14. Characteristics of RCTs Statistical methods used to compare groups • Number Needed to treat 107 patients (30-40 years old) with mild periodontitis GingiFree Placebo No Inflammation 51 38 Inflammation 4 14 How many people do you need to treat with GingiFree to prevent 1 additional inflammation? Number Needed to Treat (NNT) = 1/ARR 1 / 19.6 = 5.1
  • 15. Characteristics of RCTs Statistical methods used to compare groups 107 patients (30-40 years old) with mild periodontitis GingiFree Placebo No Inflammation 51 38 Inflammation 4 14 What is the risk of developing inflammation in the experimental group relative to the control group? EER/CER = Relative Risk (Risk Ratio) 7.3/ 26.9 = 0.27
  • 16. Characteristics of RCTs Statistical methods used to compare groups 107 patients (30-40 years old) with mild periodontitis GingiFree Placebo No Inflammation 51 38 Inflammation 4 14 What is the Odds Ratio of the study? Odds = 4/51 = 0.078 and 14/38 = 0.368 Odds Ratio = Odds of exp/Odds of control = 0.078/0.368 = 0.21
  • 17. Critical Appraisal of the Evidence • What are the results? – How large was the treatment effect? • Relative risk, mean difference, etc. – How precise was the estimate of the treatment effect? • Confidence intervals
  • 18. Critical Appraisal of the Evidence • Can I apply the results locally? – Can the results be applied to my patients? – Were all clinically important outcomes considered? – Are the likely treatment benefits worth the potential harms and costs?
  • 21. The Basics of Critical Appraisal Critical Appraisal of RCTs Randomization The process of randomly allocating participants into one of the arms of a controlled trial. - tossing a coin - computer generated tables It assures: all factors are equal less bias in patient selection
  • 22. The Basics of Critical Appraisal Critical Appraisal of RCTs Randomization Allocation concealment The process of preventing foreknowledge of group assignment in a randomized controlled trial. The most common method of concealment is the use of opaque, sealed envelopes.
  • 23. The Basics of Critical Appraisal Critical Appraisal of RCTs Randomization Allocation concealment Blinding The process of preventing those involved in a trial from knowing to which comparison group a particular participant belongs.
  • 24. The Basics of Critical Appraisal Critical Appraisal of RCTs Randomization Allocation concealment Blinding Intention to treat analysis Analysis by which all participants are included in the arm to which they were allocated, whether or not they received (or completed) the intervention given to that arm. Intention-to-treat analysis prevents bias caused by the loss of participants
  • 25. The Basics of Critical Appraisal Critical Appraisal of RCTs 107 patients (30-40 years old) with mild periodontitis GingiFree Placebo No Inflammation 51 38 Inflammation 4 14 What is the odds of inflammation in the GingiFree group relative to placebo? Odds 4/51= 0.07 14/38=0.37 Odds Ratio = 0.07/ 0.37= 0.23